1370726-04-7

Basic information

• Product Name: (S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl azide
• Synonyms: (S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl azide
• CAS NO: 1370726-04-7
• Molecular Weight: 283.176
• Mol File: 1370726-04-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl azide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl azide(1370726-04-7)
• EPA Substance Registry System: (S)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl azide(1370726-04-7)

Safety Data

• Hazardous Substances Data: 1370726-04-7(Hazardous Substances Data)

Upstream product

• 1351520-15-4 (R)-1-bromo-1-[3,5-bis(trifluoromethyl)phenyl]ethane 
• 225920-05-8 (S)-3,5-bis(trifluoromethyl)-1-phenylethanol 

Downstream Products

• 127733-40-8 (S)-α-(3,5-bis(trifluoromethyl)phenyl)ethylamine 

Relevant articles and documents

AGENT FOR INHIBITING EXPRESSION OF NPC1L1 AND/OR LIPG MRNA AND AGENT FOR PREVENTING AND/OR TREATING OBESITY

Provided is an agent for treating and/or preventing obesity. An agent for suppressing expression of NPC1L1 (Niemann-Pick disease, type C1, gene-like 1) and/or LIPG (Lipase, endothelial) mRNA, and an agent for preventing and/or treating obesity, each comprising, as an active ingredient, a compound having CETP inhibitory activity, or a salt thereof, or a solvate thereof.

OPTICALLY ACTIVE DIBENZYLAMINE DERIVATIVE, AND MANUFACTURING METHOD FOR SAME

Substantially optically pure (S)-trans-{4-[({2-[({1-[3,5-bis(trifluoromethyl)phenyl]ethyl}{5-[2-(methylsulfonyl)ethoxy]pyrimidin-2-yl}amino)methyl]-4-(trifluoromethyl)phenyl}(ethyl)amino)methyl]cyclohexyl}acetic acid, or a salt thereof, or a solvate thereof, which has actions of reducing amount of PCSK9 protein and increasing amount of LDL receptor.